Sarah L. Heringer

Sarah L. Heringer

Share this post

Sarah L. Heringer
Sarah L. Heringer
The GLP-1 Con: How The Obesity Industry Built a Billion-Dollar Market for a Problem They Created

The GLP-1 Con: How The Obesity Industry Built a Billion-Dollar Market for a Problem They Created

They engineered metabolic dysfunction, profited from the damage, and now they’re selling you the “cure.” But what happens when the weight comes back—and your health is worse than before?

Sarah L. Heringer's avatar
Sarah L. Heringer
Feb 18, 2025
∙ Paid
2

Share this post

Sarah L. Heringer
Sarah L. Heringer
The GLP-1 Con: How The Obesity Industry Built a Billion-Dollar Market for a Problem They Created
1
Share

**As a holistic health practitioner and nutritionist, I work with clients who are on GLP-1 drugs. This isn’t just an opinion-it’s what I see happening in real time. The long-term metabolic consequences of these drugs are predictable, yet rarely discussed. I help my clients navigate these challenges, ensuring that their metabolism, muscle health, and lon…

Keep reading with a 7-day free trial

Subscribe to Sarah L. Heringer to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 Sarah L. Heringer
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share